These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29513060)

  • 1. Exploitation of microbial forensics and nanotechnology for the monitoring of emerging pathogens.
    Bokhari H
    Crit Rev Microbiol; 2018 Aug; 44(4):504-521. PubMed ID: 29513060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New technologies in predicting, preventing and controlling emerging infectious diseases.
    Christaki E
    Virulence; 2015; 6(6):558-65. PubMed ID: 26068569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Emerging Zoonotic Pathogens: An Integrated One Health Approach.
    Bird BH; Mazet JAK
    Annu Rev Anim Biosci; 2018 Feb; 6():121-139. PubMed ID: 29144769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syndromic surveillance for the detection of outbreaks of unusual infectious diseases].
    van den Wijngaard CC; van Asten L; van Vliet JA; van Pelt W; Koopmans M
    Ned Tijdschr Geneeskd; 2005 Oct; 149(40):2243-5. PubMed ID: 16235804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease.
    Rotz LD; Hughes JM
    Nat Med; 2004 Dec; 10(12 Suppl):S130-6. PubMed ID: 15577931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging and endemic zoonotic diseases: surveillance and diagnostics.
    Stevenson M; Halpin K
    Rev Sci Tech; 2021 Jun; 40(1):119-129. PubMed ID: 34140736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of diagnosing infectious pathogens using colloidal nanomaterials.
    Kim J; Mohamed MAA; Zagorovsky K; Chan WCW
    Biomaterials; 2017 Nov; 146():97-114. PubMed ID: 28898761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated, laboratory-based system using the Internet for disease outbreak detection, the Netherlands.
    Widdowson MA; Bosman A; van Straten E; Tinga M; Chaves S; van Eerden L; van Pelt W
    Emerg Infect Dis; 2003 Sep; 9(9):1046-52. PubMed ID: 14519238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergent pathogens, international surveillance and international health regulations (2005)].
    Formenty P; Roth C; Gonzalez-Martin F; Grein T; Ryan M; Drury P; Kindhauser MK; Rodier G
    Med Mal Infect; 2006 Jan; 36(1):9-15. PubMed ID: 16309873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases.
    Heymann DL; Rodier GR;
    Lancet Infect Dis; 2001 Dec; 1(5):345-53. PubMed ID: 11871807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools for the Microbiome: Nano and Beyond.
    Biteen JS; Blainey PC; Cardon ZG; Chun M; Church GM; Dorrestein PC; Fraser SE; Gilbert JA; Jansson JK; Knight R; Miller JF; Ozcan A; Prather KA; Quake SR; Ruby EG; Silver PA; Taha S; van den Engh G; Weiss PS; Wong GC; Wright AT; Young TD
    ACS Nano; 2016 Jan; 10(1):6-37. PubMed ID: 26695070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current molecular and emerging nanobiotechnology approaches for the detection of microbial pathogens.
    Theron J; Eugene Cloete T; de Kwaadsteniet M
    Crit Rev Microbiol; 2010 Nov; 36(4):318-39. PubMed ID: 20879848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging trends in foodborne diseases.
    Braden CR; Tauxe RV
    Infect Dis Clin North Am; 2013 Sep; 27(3):517-33. PubMed ID: 24011828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recognition of the threats caused by infectious diseases in The Netherlands in 2002 and 2003 by the weekly meetings of the early warning committee].
    Rahamat-Langendoen JC; van Vliet JA; Suijkerbuijk AW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(40):2238-42. PubMed ID: 16235803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Public health surveillance and assessment of emerging infectious threats: method and criteria for risk analysis].
    Bitar D; Che D; Capek I; de Valk H; Saura C
    Med Mal Infect; 2011 Feb; 41(2):53-62. PubMed ID: 21251782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance strategy for early detection of unusual infectious disease events.
    Koopmans M
    Curr Opin Virol; 2013 Apr; 3(2):185-91. PubMed ID: 23612329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology and the diagnosis of dermatological infectious disease.
    Blecher Paz K; Friedman A
    J Drugs Dermatol; 2012 Jul; 11(7):846-51. PubMed ID: 22777227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in in-vitro nanodiagnostics for detection of pathogens.
    Shinde SB; Fernandes CB; Patravale VB
    J Control Release; 2012 Apr; 159(2):164-80. PubMed ID: 22192572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing emerging and reemerging infectious diseases: the pivotal role of the pathologist.
    Olano JP; Walker DH
    Arch Pathol Lab Med; 2011 Jan; 135(1):83-91. PubMed ID: 21204714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Capacity for Emerging Infectious Disease Detection, 1996-2014.
    Kluberg SA; Mekaru SR; McIver DJ; Madoff LC; Crawley AW; Smolinski MS; Brownstein JS
    Emerg Infect Dis; 2016 Oct; 22(10):E1-6. PubMed ID: 27649306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.